<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Paradisi G</submitter><funding>Telethon Foundation</funding><funding>Ministry of Health</funding><pagination>63-82</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12835968</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>143</volume><pubmed_abstract>Pathogenic variants in COL4A1 and COL4A2, encoding type IV collagen α1 and α2 chains-core components of all basement membranes-cause a multisystem disorder with variable expressivity. Affected individuals commonly present with cerebral small vessel disease (cSVD), unmanageable intracerebral haemorrhage (ICH), drug-resistant epilepsy, microphthalmia, and congenital cataract. Severe phenotypes are often linked to glycine substitutions that disrupt α1/α2 heterotrimer assembly, though insertions, deletions, and haploinsufficiency seem to also be pathogenic. Limited insight into collagen IV α1 and α2 biology and how specific variants affect their functions-coupled with a lack of rapid in vivo assays for functional variants classification-hampers patient stratification and therapy development. H</pubmed_abstract><journal>Matrix biology : journal of the International Society for Matrix Biology</journal><pubmed_title>Zebrafish col4a1 loss-of-function models mirror key neurovascular and ocular features of COL4A1/A2 syndrome and enable human variants assessment in vivo.</pubmed_title><pmcid>PMC12835968</pmcid><funding_grant_id>RF-2021-12374963</funding_grant_id><funding_grant_id>5\u00D71000</funding_grant_id><pubmed_authors>Venditti M</pubmed_authors><pubmed_authors>Bonavolonta V</pubmed_authors><pubmed_authors>Paradisi G</pubmed_authors><pubmed_authors>Fasano G</pubmed_authors><pubmed_authors>Pedalino C</pubmed_authors><pubmed_authors>Lauri A</pubmed_authors><pubmed_authors>Tartaglia M</pubmed_authors><pubmed_authors>Del Bene F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Zebrafish col4a1 loss-of-function models mirror key neurovascular and ocular features of COL4A1/A2 syndrome and enable human variants assessment in vivo.</name><description>Pathogenic variants in COL4A1 and COL4A2, encoding type IV collagen α1 and α2 chains-core components of all basement membranes-cause a multisystem disorder with variable expressivity. Affected individuals commonly present with cerebral small vessel disease (cSVD), unmanageable intracerebral haemorrhage (ICH), drug-resistant epilepsy, microphthalmia, and congenital cataract. Severe phenotypes are often linked to glycine substitutions that disrupt α1/α2 heterotrimer assembly, though insertions, deletions, and haploinsufficiency seem to also be pathogenic. Limited insight into collagen IV α1 and α2 biology and how specific variants affect their functions-coupled with a lack of rapid in vivo assays for functional variants classification-hampers patient stratification and therapy development. H</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-06-17T06:58:47.246Z</modification><creation>2026-06-17T03:10:45.004Z</creation></dates><accession>S-EPMC12835968</accession><cross_references><pubmed>41248836</pubmed><doi>10.1016/j.matbio.2025.11.004</doi></cross_references></HashMap>